Efficacy of Eductyl® Versus Placebo for Treatment of Dyschesia
NCT ID: NCT00910832
Last Updated: 2014-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
306 participants
INTERVENTIONAL
2009-05-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
NCT02137642
Psyllium Fiber Versus Placebo in Early Treatment After STARR for Obstructed Defecation: a Double-blind RCT
NCT02136693
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
NCT01781104
Dulcolax vs Placebo in Functional Constipation
NCT00526097
Effectiveness of Docusate in Preventing/Treating Constipation in Palliative Care Patients
NCT00902031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eductyl suppository
Eductyl suppository
one suppository every morning during 21 days
Placebo suppository
Placebo suppository
placebo suppository every morning during 21 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eductyl suppository
one suppository every morning during 21 days
Placebo suppository
placebo suppository every morning during 21 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with dyschesia
* Prescription of rehabilitation for dyschesia
Exclusion Criteria
* Pain killers
* Pregnant women
* Breast feeding patients
* Non-compliant patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoires Techni Pharma
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Odile Cotelle, Dr
Role: PRINCIPAL_INVESTIGATOR
Diaconesses hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diaconesses Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cotelle O, Cargill G, Marty MM, Bueno L, Cappelletti MC, Colangeli-Hagege H, Savarieau B, Ducrotte P. A concomitant treatment by CO2-releasing suppositories improves the results of anorectal biofeedback training in patients with dyschezia: results of a randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2014 Jun;57(6):781-9. doi: 10.1097/DCR.0000000000000098.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EudraCT N° : 2007-0003658-27
Identifier Type: -
Identifier Source: secondary_id
07-EDU-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.